Posted on May 30, 2013

3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural MesotheliomaOn Saturday, May 18 in Santa Monica, California, ADAO had the opportunity to present on “The Global Asbestos Struggle: Progress and Challenges” at the 3rd International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma.

The symposium, which is the only U.S. conference dedicated to lung-sparing therapies for mesothelioma, brought together renowned mesothelioma experts from North America and Europe. The symposium was once again chaired by Dr. Robert Cameron, the Director of the Comprehensive Mesothelioma Program at UCLA, and prestigious faculty members, including Dr. Joseph Friedberg, Co-Director of the Penn Mesothelioma & Pleural Program at the University of Pennsylvania, and Dr. Raffit Hassan of the Head, Solid Tumor Immunotherapy Section at the National Cancer Institute. ADAO was the only asbestos victims’ organization invited to present among these esteemed doctors.

ADAO applauds Dr. Cameron and his colleagues at UCLA’s David Geffen School of Medicine for their efforts to educate the medical community on the advancements in mesothelioma treatment. It was terrific to see oncologists, pulmonary physicians, mesothelioma experts, and patients and families gather to share the latest information on choosing mesothelioma treatment options.

In unity,

Linda

Social Networks

Click here to view the Symposium’s official brochure